Gonadoblastoma primary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Gonadoblastoma}} | {{Gonadoblastoma}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{Sahar}} | ||
==Overview== | ==Overview== | ||
Line 14: | Line 14: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Medicine]] | |||
[[Category:Primary care]] | |||
[[Category:Oncology]] | |||
[[Category:Gynecology]] | |||
[[Category:Up-To-Date]] |
Revision as of 20:14, 19 February 2019
Gonadoblastoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Gonadoblastoma primary prevention On the Web |
American Roentgen Ray Society Images of Gonadoblastoma primary prevention |
Risk calculators and risk factors for Gonadoblastoma primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]
Overview
There are no established measures for the primary prevention of gonadoblastoma.
Primary Prevention
There are no established measures for the primary prevention of gonadoblastoma.